SecBot SecBot
8-K ·Filed May 6, 2026

XNCR

Xencor Inc
BEARISH
Impact 7/10
Horizondays Processed6mo ago SEC0001326732-26-000042
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The sharp revenue drop and widened loss will likely pressure XNCR shares near-term. Key catalysts remain XmAb819 data in 2H26 and XmAb412 trial start in 3Q26. Monitor cash burn trajectory and any partnership milestone updates.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.31
T+0 close · May 6, 2026 · via day close
Latest settled
+57.60%
T+60 · $19.40
Vs SPY
+53.76%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $12.31entry
  2. T+1 · 6mo ago 0.00%α −0.83% · $12.31
  3. T+5 · 6mo ago +0.57%α −0.94% · $12.38
  4. T+20 · 6mo ago −7.23%α −10.37% · $11.42
  5. T+60 · 4mo ago +57.60%α +53.76% · $19.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Xencor reported Q1 2026 revenue of $4.5M (down 86% YoY) and a net loss of $128.9M ($1.71 per share), massively missing consensus estimates of a $0.65 loss per share. The quarter lacked milestone revenue that boosted prior-year results, and cash burn remains high, with year-end cash guidance lowered to $380-400M.

Key Financial Metrics

EPS
−$1.71
est −$0.65 · -163.1%
Revenue
$4.5M
-86.2% YoY
Rating
strong miss

Key Facts

  • Q1 2026 revenue fell 86% YoY to $4.5M from $32.7M
  • EPS of -$1.71 missed consensus estimate of -$0.65 (-163% surprise)
  • Net loss widened to $128.9M from $48.4M in Q1 2025
  • Cash and securities decreased to $541.8M from $610.8M at year-end 2025
  • Year-end 2026 cash guidance lowered to $380-400M from prior $400-430M
  • Pipeline milestones on track (XmAb819 expansion data 2H26, XmAb412 FIH 3Q26)

Financial Impact

Revenue decline of $28.2M YoY; net loss increase of $80.5M; EPS miss of $1.06 vs consensus

revenueepsnet incomecash guidance

Risk Factors

  • Lowered cash guidance signals higher than expected burn or delayed milestones
  • Dependence on partnership milestones for meaningful revenue
  • Clinical trial delays or negative data could further pressure valuation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001326732-26-000042
Document: xncr-20260506.htm0001326732-26-000042
Document: 0001326732-26-000042-index-headers.html0001326732-26-000042
Document: 0001326732-26-000042-index.html0001326732-26-000042
Document: 0001326732-26-000042.txt0001326732-26-000042
8-K Data (Synthetic)0001326732-26-000042

Track record

20 reports on XNCR

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
  2. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
  3. Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
  6. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
  7. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
  8. Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
  9. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026